Contents
Current Cancer Drug Targets, Volume 10 - Number 3
Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
, 10(3): 268 - 278N. Ahmed, K. Abubaker, J. Findlay and M. Quinn
DOI: 10.2174/156800910791190175
In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin
, 10(3): 279 - 286A. Gonzalez, V. Alvarez-Garcia, C. Martinez-Campa, M.D. Mediavilla, C. Alonso-Gonzalez, E.J. Sanchez-Barcelo and S. Cos
DOI: 10.2174/156800910791190201
CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
, 10(3): 287 - 306J.L. Hao, P.J. Cozzi, A. Khatri, C.A. Power and Y. Li
DOI: 10.2174/156800910791190193
Persistent P21Cip1 Induction Mediates G1 Cell Cycle Arrest by Methylseleninic Acid in DU145 Prostate Cancer Cells
, 10(3): 307 - 318Z. Wang, H.-J. Lee, Y. Chai, H. Hu, L. Wang, Y. Zhang, C. Jiang and J. Lu
DOI: 10.2174/156800910791190238
Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy
, 10(3): 319 - 331A.S. Azmi, P.A. Philip, A. Aboukameel, Z. Wang, S. Banerjee, S.F. Zafar, A.-S. Goustin, K. Almhanna, D. Yang, F.H. Sarkar and R.M. Mohammad
DOI: 10.2174/156800910791190229
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
, 10(3): 332 - 342I. Kenessey, M. Keszthelyi, Z. Kramer, J. Berta, A. Adam, J. Dobos, M. Mildner, B. Flachner, S. Cseh, G. Barna, B. Szokol, L. Orfi, G. Keri, B. Dome, W. Klepetko, J. Timar and J. Tovari
DOI: 10.2174/156800910791190184
A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy
, 10(3): 343 - 353S.R. Paliwal, R. Paliwal, N. Mishra, A. Mehta and S.P. Vyas
DOI: 10.2174/156800910791190210
Webmaster Contact: info@benthamscience.org